A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations
Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is therapeutically challenging and aggressive. MpBC is defined by the histological presence of at least two cellular types, typically epithelial and mesenchymal components. This variant harbors a triple-negative breas...
Saved in:
| Published in | Breast cancer research : BCR Vol. 22; no. 1; pp. 121 - 11 |
|---|---|
| Main Authors | , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
London
BioMed Central
04.11.2020
BioMed Central Ltd BMC |
| Subjects | |
| Online Access | Get full text |
| ISSN | 1465-542X 1465-5411 1465-542X |
| DOI | 10.1186/s13058-020-01353-z |
Cover
| Abstract | Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is therapeutically challenging and aggressive. MpBC is defined by the histological presence of at least two cellular types, typically epithelial and mesenchymal components. This variant harbors a triple-negative breast cancer (TNBC) phenotype, yet has a worse prognosis and decreased survival compared to TNBC. There are currently no standardized treatment guidelines specifically for MpBC. However, prior studies have found that MpBC typically has molecular alterations in epithelial-to-mesenchymal transition, amplification of epidermal growth factor receptor, PI3K/Akt signaling, nitric oxide signaling, Wnt/β-catenin signaling, altered immune response, and cell cycle dysregulation. Some of these molecular alterations have been studied as therapeutic targets, in both the preclinical and clinical setting. This current review discusses the histological organization and cellular origins of MpBC, molecular alterations, the role of radiation therapy, and current clinical trials for MpBC. |
|---|---|
| AbstractList | Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is therapeutically challenging and aggressive. MpBC is defined by the histological presence of at least two cellular types, typically epithelial and mesenchymal components. This variant harbors a triple-negative breast cancer (TNBC) phenotype, yet has a worse prognosis and decreased survival compared to TNBC. There are currently no standardized treatment guidelines specifically for MpBC. However, prior studies have found that MpBC typically has molecular alterations in epithelial-to-mesenchymal transition, amplification of epidermal growth factor receptor, PI3K/Akt signaling, nitric oxide signaling, Wnt/β-catenin signaling, altered immune response, and cell cycle dysregulation. Some of these molecular alterations have been studied as therapeutic targets, in both the preclinical and clinical setting. This current review discusses the histological organization and cellular origins of MpBC, molecular alterations, the role of radiation therapy, and current clinical trials for MpBC. Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is therapeutically challenging and aggressive. MpBC is defined by the histological presence of at least two cellular types, typically epithelial and mesenchymal components. This variant harbors a triple-negative breast cancer (TNBC) phenotype, yet has a worse prognosis and decreased survival compared to TNBC. There are currently no standardized treatment guidelines specifically for MpBC. However, prior studies have found that MpBC typically has molecular alterations in epithelial-to-mesenchymal transition, amplification of epidermal growth factor receptor, PI3K/Akt signaling, nitric oxide signaling, Wnt/β-catenin signaling, altered immune response, and cell cycle dysregulation. Some of these molecular alterations have been studied as therapeutic targets, in both the preclinical and clinical setting. This current review discusses the histological organization and cellular origins of MpBC, molecular alterations, the role of radiation therapy, and current clinical trials for MpBC.Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is therapeutically challenging and aggressive. MpBC is defined by the histological presence of at least two cellular types, typically epithelial and mesenchymal components. This variant harbors a triple-negative breast cancer (TNBC) phenotype, yet has a worse prognosis and decreased survival compared to TNBC. There are currently no standardized treatment guidelines specifically for MpBC. However, prior studies have found that MpBC typically has molecular alterations in epithelial-to-mesenchymal transition, amplification of epidermal growth factor receptor, PI3K/Akt signaling, nitric oxide signaling, Wnt/β-catenin signaling, altered immune response, and cell cycle dysregulation. Some of these molecular alterations have been studied as therapeutic targets, in both the preclinical and clinical setting. This current review discusses the histological organization and cellular origins of MpBC, molecular alterations, the role of radiation therapy, and current clinical trials for MpBC. Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is therapeutically challenging and aggressive. MpBC is defined by the histological presence of at least two cellular types, typically epithelial and mesenchymal components. This variant harbors a triple-negative breast cancer (TNBC) phenotype, yet has a worse prognosis and decreased survival compared to TNBC. There are currently no standardized treatment guidelines specifically for MpBC. However, prior studies have found that MpBC typically has molecular alterations in epithelial-to-mesenchymal transition, amplification of epidermal growth factor receptor, PI3K/Akt signaling, nitric oxide signaling, Wnt/[beta]-catenin signaling, altered immune response, and cell cycle dysregulation. Some of these molecular alterations have been studied as therapeutic targets, in both the preclinical and clinical setting. This current review discusses the histological organization and cellular origins of MpBC, molecular alterations, the role of radiation therapy, and current clinical trials for MpBC. Abstract Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is therapeutically challenging and aggressive. MpBC is defined by the histological presence of at least two cellular types, typically epithelial and mesenchymal components. This variant harbors a triple-negative breast cancer (TNBC) phenotype, yet has a worse prognosis and decreased survival compared to TNBC. There are currently no standardized treatment guidelines specifically for MpBC. However, prior studies have found that MpBC typically has molecular alterations in epithelial-to-mesenchymal transition, amplification of epidermal growth factor receptor, PI3K/Akt signaling, nitric oxide signaling, Wnt/β-catenin signaling, altered immune response, and cell cycle dysregulation. Some of these molecular alterations have been studied as therapeutic targets, in both the preclinical and clinical setting. This current review discusses the histological organization and cellular origins of MpBC, molecular alterations, the role of radiation therapy, and current clinical trials for MpBC. Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is therapeutically challenging and aggressive. MpBC is defined by the histological presence of at least two cellular types, typically epithelial and mesenchymal components. This variant harbors a triple-negative breast cancer (TNBC) phenotype, yet has a worse prognosis and decreased survival compared to TNBC. There are currently no standardized treatment guidelines specifically for MpBC. However, prior studies have found that MpBC typically has molecular alterations in epithelial-to-mesenchymal transition, amplification of epidermal growth factor receptor, PI3K/Akt signaling, nitric oxide signaling, Wnt/[beta]-catenin signaling, altered immune response, and cell cycle dysregulation. Some of these molecular alterations have been studied as therapeutic targets, in both the preclinical and clinical setting. This current review discusses the histological organization and cellular origins of MpBC, molecular alterations, the role of radiation therapy, and current clinical trials for MpBC. Keywords: Metaplastic breast cancer, PI3K signaling, NOS signaling, Epithelial-to-mesenchymal transition |
| ArticleNumber | 121 |
| Audience | Academic |
| Author | Li, Xiaoxian Rosato, Roberto R. Moulder, Stacy Piwnica-Worms, Helen Reddy, Tejaswini P. Chang, Jenny C. |
| Author_xml | – sequence: 1 givenname: Tejaswini P. surname: Reddy fullname: Reddy, Tejaswini P. organization: Houston Methodist Research Institute, Texas A&M Health Science Center College of Medicine – sequence: 2 givenname: Roberto R. surname: Rosato fullname: Rosato, Roberto R. organization: Houston Methodist Research Institute – sequence: 3 givenname: Xiaoxian surname: Li fullname: Li, Xiaoxian organization: Winship Cancer Institute, Emory University School of Medicine – sequence: 4 givenname: Stacy surname: Moulder fullname: Moulder, Stacy organization: The University of Texas MD Anderson Cancer Center – sequence: 5 givenname: Helen surname: Piwnica-Worms fullname: Piwnica-Worms, Helen organization: The University of Texas MD Anderson Cancer Center – sequence: 6 givenname: Jenny C. surname: Chang fullname: Chang, Jenny C. email: jcchang@houstonmethodist.org organization: Houston Methodist Research Institute, Houston Methodist Cancer Center/Weill Cornell Medicine |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33148288$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kk9r2zAYh8XoWNtsX2CHYdhlF3f6Y8vKDoNQ2q1Q2GWD3cRr-VWqYEuZZGesn35K0q5NGcUHC_n5PeKVf6fkyAePhLxl9IwxJT8mJmitSsppSZmoRXn7gpywStZlXfGfR4_Wx-Q0pRWlrFG1ekWOhWCV4kqdkHZRmDCsI96gT26DRdhg3Dj8XQRbDDjCuoc0OlO0EfOiMOANxk-F6Z13BvrCIoxTxFSA74oh9GimHmIBLcYIows-vSYvLfQJ39y9Z-TH5cX386_l9bcvV-eL69LIRoxlg2Dmbc41rBNYC1Zj18x5q-oOBGs5WGXQcIvWtMqArCRtu84wRqmynKKYkau9twuw0uvoBoh_dACndxshLjXEPEqP2pptGCkCx8pSq3iWVMhk3qkMbF2f96711A7YGfRjhP5AevjFuxu9DBvdyIpKKbLgw50ghl8TplEPLhnse_AYpqR5VTdzqZrMzsj7J-gqTNHnq8qU5GyeKfZALSEP4LwN-VyzleqFrDifM8GbTJ39h8pPh4MzuT7W5f2DwLvHg_6b8L4hGVB7wMSQUkSrjRt3PzabXa8Z1dsy6n0ZdS6j3pVR3-YofxK9tz8bEvtQyrBfYny4jWdSfwHVIvRG |
| CitedBy_id | crossref_primary_10_1002_ame2_12491 crossref_primary_10_3389_fmed_2021_689895 crossref_primary_10_3390_molecules27123950 crossref_primary_10_1038_s41567_024_02716_5 crossref_primary_10_1016_j_nano_2023_102669 crossref_primary_10_1002_cnr2_1997 crossref_primary_10_1038_s41563_025_02150_9 crossref_primary_10_1536_ihj_22_345 crossref_primary_10_1016_j_ctrv_2025_102885 crossref_primary_10_1016_j_bcp_2023_115459 crossref_primary_10_7759_cureus_14347 crossref_primary_10_1007_s12282_022_01350_4 crossref_primary_10_1016_j_jddst_2024_105401 crossref_primary_10_7759_cureus_53419 crossref_primary_10_1016_j_modpat_2024_100593 crossref_primary_10_61466_ijcmr2040001 crossref_primary_10_1101_gr_276059_121 crossref_primary_10_3390_cells11162558 crossref_primary_10_1186_s13058_024_01920_8 crossref_primary_10_3390_cancers15112954 crossref_primary_10_1038_s41587_024_02173_8 crossref_primary_10_1016_j_annonc_2023_10_127 crossref_primary_10_1038_s41598_023_45597_z crossref_primary_10_1038_s41598_025_87286_z crossref_primary_10_1038_s41420_021_00609_7 crossref_primary_10_1126_scisignal_abg3449 crossref_primary_10_1186_s12905_023_02513_x crossref_primary_10_4103_jcrt_jcrt_1517_21 crossref_primary_10_4103_jfmpc_jfmpc_983_23 crossref_primary_10_1016_j_breast_2024_103858 crossref_primary_10_1038_s41431_023_01429_2 crossref_primary_10_1001_jamanetworkopen_2024_60312 crossref_primary_10_1007_s10549_023_07233_2 crossref_primary_10_1016_j_senol_2021_12_002 crossref_primary_10_3892_ol_2024_14331 crossref_primary_10_1159_000525324 crossref_primary_10_1053_j_semdp_2023_02_003 crossref_primary_10_1515_biol_2022_0640 crossref_primary_10_1038_s41379_022_01017_7 crossref_primary_10_1111_his_15381 crossref_primary_10_3389_fonc_2024_1470986 crossref_primary_10_1002_ccr3_8320 crossref_primary_10_7759_cureus_65674 crossref_primary_10_1016_j_prp_2023_154994 crossref_primary_10_1111_ajco_14089 crossref_primary_10_1007_s12079_021_00657_9 crossref_primary_10_1016_j_cpccr_2023_100239 crossref_primary_10_3390_cancers16213622 crossref_primary_10_3390_ijms231911046 crossref_primary_10_15388_LietChirur_2024_23_3__7 crossref_primary_10_3389_fmed_2022_886763 crossref_primary_10_7759_cureus_15006 crossref_primary_10_1080_0284186X_2021_1950927 crossref_primary_10_1158_1078_0432_CCR_21_2182 crossref_primary_10_1159_000534146 crossref_primary_10_3389_fgene_2022_993116 crossref_primary_10_4103_jcrt_jcrt_1640_22 crossref_primary_10_1038_s41523_025_00719_w crossref_primary_10_1016_j_currproblcancer_2024_101148 crossref_primary_10_1200_PO_22_00506 crossref_primary_10_1016_j_labinv_2023_100258 crossref_primary_10_1097_PAS_0000000000002057 crossref_primary_10_1080_21655979_2021_2000198 crossref_primary_10_3390_biom14010074 crossref_primary_10_1007_s12032_023_02259_4 crossref_primary_10_1038_s41598_024_84584_w crossref_primary_10_1177_2050313X231205715 crossref_primary_10_1016_j_bcp_2021_114692 crossref_primary_10_7759_cureus_25940 crossref_primary_10_7759_cureus_56619 crossref_primary_10_1007_s00428_022_03329_0 crossref_primary_10_1186_s13058_023_01705_5 crossref_primary_10_1016_j_biopha_2024_116584 crossref_primary_10_26508_lsa_202302009 crossref_primary_10_1016_j_jpi_2023_100329 crossref_primary_10_3389_fmed_2022_827206 crossref_primary_10_3389_fonc_2022_830124 crossref_primary_10_1097_CEJ_0000000000000794 crossref_primary_10_1038_s41467_024_54651_x crossref_primary_10_1016_j_ijrobp_2024_06_016 crossref_primary_10_1111_his_14770 crossref_primary_10_7759_cureus_22029 crossref_primary_10_3390_ijms22147694 crossref_primary_10_1148_rg_230034 crossref_primary_10_1007_s00129_023_05176_9 crossref_primary_10_1016_j_cll_2023_03_002 crossref_primary_10_3389_fonc_2024_1362024 crossref_primary_10_3389_fendo_2022_810747 crossref_primary_10_33262_anatomiadigital_v6i3_2617 crossref_primary_10_1155_2024_2540356 crossref_primary_10_1007_s10549_023_06945_9 crossref_primary_10_1155_2022_8471331 crossref_primary_10_1186_s13058_024_01888_5 crossref_primary_10_20862_0042_4676_2022_103_4_6_88_93 crossref_primary_10_3389_fonc_2022_924342 crossref_primary_10_3389_fonc_2023_1030124 crossref_primary_10_1007_s13258_022_01262_9 crossref_primary_10_2147_BCTT_S395944 crossref_primary_10_1016_j_path_2021_11_011 crossref_primary_10_1038_s41598_022_27093_y crossref_primary_10_1093_jscr_rjad144 |
| Cites_doi | 10.1186/s12967-019-2069-y 10.1038/s41467-020-15283-z 10.1186/s13058-015-0527-x 10.1158/0008-5472.CAN-07-2017 10.1002/path.5091 10.1038/nrc.2017.118 10.1073/pnas.1004900107 10.1097/PAS.0b013e31818ab26e 10.1016/j.tranon.2020.100773 10.1007/s00262-012-1283-8 10.1016/j.ccell.2018.08.008 10.1634/theoncologist.2017-0398 10.1002/(SICI)1097-0142(19980315)82:6<1082::AID-CNCR11>3.0.CO;2-2 10.1200/JCO.2020.38.15_suppl.1073 10.1158/1078-0432.CCR-07-4379 10.1245/s10434-014-3890-4 10.1172/JCI39104 10.1186/bcr1341 10.1186/1477-7819-11-129 10.1097/01.pas.0000138183.97366.fd 10.1093/jnci/djw292 10.1007/s10549-011-1359-8 10.1016/j.jfma.2018.12.004 10.1172/JCI45014 10.1146/annurev.cellbio.17.1.615 10.1002/path.5184 10.1038/onc.2016.381 10.1186/s12885-019-6052-z 10.1245/s10434-010-1198-6 10.1038/s41523-017-0011-0 10.1186/2162-3619-2-31 10.1038/s41379-018-0081-z 10.1615/CritRevOncog.2017021307 10.1158/1078-0432.CCR-16-2857 10.1097/MD.0000000000002341 10.1097/01.pas.0000152133.60278.d2 10.1097/00000478-199802000-00006 10.1111/his.13514 10.1038/nrc3637 10.5858/arpa.2019-0396-RA 10.1007/s10549-010-0780-8 10.1001/jamaoncol.2016.5281 10.1002/path.2004 10.1158/1535-7163.MCT-07-0570 10.1158/0008-5472.CAN-08-3441 10.1007/s10549-011-1686-9 10.1038/modpathol.2010.141 10.1097/00000478-198712000-00002 10.1073/pnas.0905718106 10.1038/nrclinonc.2018.28 10.1136/jcp.2005.030536 10.1371/journal.pone.0224726 10.1136/jclinpath-2016-203874 |
| ContentType | Journal Article |
| Copyright | The Author(s) 2020 COPYRIGHT 2020 BioMed Central Ltd. 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s) 2020 – notice: COPYRIGHT 2020 BioMed Central Ltd. – notice: 2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7TO 7X7 7XB 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S PHGZM PHGZT PIMPY PKEHL PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s13058-020-01353-z |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Health Research Premium Collection (UHCL Subscription) Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Proquest Central Premium ProQuest One Academic (New) ProQuest Publicly Available Content Database ProQuest One Academic Middle East (New) ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest One Academic Eastern Edition ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Central China ProQuest Hospital Collection (Alumni) ProQuest Central ProQuest Health & Medical Complete Health Research Premium Collection ProQuest One Academic UKI Edition Health and Medicine Complete (Alumni Edition) ProQuest Central Korea AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic Publicly Available Content Database MEDLINE |
| Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals (Selected full-text) url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 3 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 4 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Anatomy & Physiology |
| EISSN | 1465-542X |
| EndPage | 11 |
| ExternalDocumentID | oai_doaj_org_article_fc60bde0ea2e4f0f820084e160ea4cae PMC7640663 A642291327 33148288 10_1186_s13058_020_01353_z |
| Genre | Journal Article Review |
| GrantInformation_xml | – fundername: Breast Cancer Research Fund (US) – fundername: ; |
| GroupedDBID | --- 04C 0R~ 23N 2WC 4.4 53G 5GY 5VS 6J9 7X7 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABUWG ACGFO ACGFS ACJQM ACMJI ACPRK ADBBV ADFRT ADUKV AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIAM AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BMSDO BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EIHBH F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO ICW IHR INH INR ITC KQ8 O5R O5S OK1 P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PUEGO RBZ ROL RPM RSV SBL SOJ TR2 U2A UKHRP WOQ AAYXX ALIPV CITATION CGR CUY CVF ECM EIF NPM PMFND 3V. 7TO 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c673t-7eac9babe71d3e5315ed792b85da31b2af8cec2fefcb8ca6460bddc11008f20e3 |
| IEDL.DBID | 7X7 |
| ISSN | 1465-542X 1465-5411 |
| IngestDate | Wed Aug 27 01:23:23 EDT 2025 Thu Aug 21 18:22:15 EDT 2025 Fri Sep 05 12:15:28 EDT 2025 Mon Jun 30 02:10:03 EDT 2025 Tue Jun 17 21:46:16 EDT 2025 Tue Jun 10 20:20:51 EDT 2025 Thu Apr 03 06:57:33 EDT 2025 Thu Apr 24 23:12:25 EDT 2025 Tue Jul 01 02:43:13 EDT 2025 Sat Sep 06 07:25:06 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Metaplastic breast cancer PI3K signaling Epithelial-to-mesenchymal transition NOS signaling |
| Language | English |
| License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c673t-7eac9babe71d3e5315ed792b85da31b2af8cec2fefcb8ca6460bddc11008f20e3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://www.proquest.com/docview/2462198761?pq-origsite=%requestingapplication% |
| PMID | 33148288 |
| PQID | 2462198761 |
| PQPubID | 2034567 |
| PageCount | 11 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_fc60bde0ea2e4f0f820084e160ea4cae pubmedcentral_primary_oai_pubmedcentral_nih_gov_7640663 proquest_miscellaneous_2457968766 proquest_journals_2462198761 gale_infotracmisc_A642291327 gale_infotracacademiconefile_A642291327 pubmed_primary_33148288 crossref_citationtrail_10_1186_s13058_020_01353_z crossref_primary_10_1186_s13058_020_01353_z springer_journals_10_1186_s13058_020_01353_z |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2020-11-04 |
| PublicationDateYYYYMMDD | 2020-11-04 |
| PublicationDate_xml | – month: 11 year: 2020 text: 2020-11-04 day: 04 |
| PublicationDecade | 2020 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | Breast cancer research : BCR |
| PublicationTitleAbbrev | Breast Cancer Res |
| PublicationTitleAlternate | Breast Cancer Res |
| PublicationYear | 2020 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | D Sarrio (1353_CR39) 2008; 68 RJ Brenner (1353_CR6) 1998; 82 S Adams (1353_CR59) 2020; 38 MM Koker (1353_CR14) 2004; 28 S Leibl (1353_CR19) 2005; 29 Y Song (1353_CR12) 2013; 11 1353_CR26 EE Martin (1353_CR33) 2017; 36 SY Jung (1353_CR52) 2010; 120 JS Reis-Filho (1353_CR23) 2005; 7 AG Huvos (1353_CR5) 1973; 73 R Katso (1353_CR43) 2001; 17 ER McMullen (1353_CR8) 2019; 143 B Dave (1353_CR30) 2017; 109 Y Li (1353_CR56) 2019; 17 SY Bae (1353_CR45) 2011; 126 MC Schroeder (1353_CR53) 2018; 23 BT Hennessy (1353_CR21) 2009; 69 T Brabletz (1353_CR41) 2018; 18 G Bataillon (1353_CR15) 2018; 73 CKY Ng (1353_CR27) 2017; 23 HA Oberman (1353_CR11) 1987; 11 JS Reis-Filho (1353_CR24) 2006; 209 D Ribatti (1353_CR40) 2020; 13 B Weigelt (1353_CR3) 2014; 14 MH Yang (1353_CR58) 2019; 118 EM Walsh (1353_CR48) 2016; 21 RA Nelson (1353_CR4) 2015; 22 JH Taube (1353_CR20) 2010; 107 GM Tse (1353_CR10) 2006; 59 C Chhieng (1353_CR18) 1998; 22 TL Schwartz (1353_CR9) 2013; 2 1353_CR1 MJ Hayes (1353_CR31) 2008; 14 E Nowara (1353_CR55) 2014; 18 1353_CR2 JA Gilbert (1353_CR25) 2008; 7 IC Chen (1353_CR50) 2011; 130 M Ruas (1353_CR49) 1998; 1378 CJ Creighton (1353_CR22) 2009; 106 E Downs-Kelly (1353_CR13) 2009; 33 AC Herrera (1353_CR47) 2012; 61 RK Basho (1353_CR57) 2017; 3 WH Tseng (1353_CR54) 2011; 18 S Granados-Principal (1353_CR29) 2015; 17 A Aydiner (1353_CR46) 2015; 94 AE McCart Reed (1353_CR7) 2019; 247 SI Djomehri (1353_CR17) 2020; 11 JA McQuerry (1353_CR16) 2019; 19 1353_CR51 G Krings (1353_CR36) 2018; 31 U Joneja (1353_CR34) 2017; 70 M Afkhami (1353_CR28) 2019; 14 S Adams (1353_CR35) 2017; 3 S Bartels (1353_CR37) 2018; 245 R Kalluri (1353_CR38) 2009; 119 M Lacroix-Triki (1353_CR32) 2010; 23 F Janku (1353_CR44) 2018; 15 BD Lehmann (1353_CR42) 2011; 121 |
| References_xml | – volume: 17 start-page: 318 issue: 1 year: 2019 ident: 1353_CR56 publication-title: J Transl Med doi: 10.1186/s12967-019-2069-y – volume: 11 start-page: 1723 issue: 1 year: 2020 ident: 1353_CR17 publication-title: Nat Commun doi: 10.1038/s41467-020-15283-z – volume: 17 start-page: 25 year: 2015 ident: 1353_CR29 publication-title: Breast Cancer Res doi: 10.1186/s13058-015-0527-x – volume: 1378 start-page: F115 issue: 2 year: 1998 ident: 1353_CR49 publication-title: Biochim Biophys Acta – volume: 68 start-page: 989 issue: 4 year: 2008 ident: 1353_CR39 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-07-2017 – ident: 1353_CR2 – volume: 245 start-page: 373 issue: 3 year: 2018 ident: 1353_CR37 publication-title: J Pathol doi: 10.1002/path.5091 – volume: 18 start-page: 128 issue: 2 year: 2018 ident: 1353_CR41 publication-title: Nat Rev Cancer doi: 10.1038/nrc.2017.118 – volume: 107 start-page: 15449 issue: 35 year: 2010 ident: 1353_CR20 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.1004900107 – volume: 33 start-page: 534 issue: 4 year: 2009 ident: 1353_CR13 publication-title: Am J Surg Pathol doi: 10.1097/PAS.0b013e31818ab26e – volume: 13 start-page: 100773 issue: 6 year: 2020 ident: 1353_CR40 publication-title: Transl Oncol doi: 10.1016/j.tranon.2020.100773 – volume: 61 start-page: 2193 issue: 11 year: 2012 ident: 1353_CR47 publication-title: Cancer Immunol Immunother doi: 10.1007/s00262-012-1283-8 – ident: 1353_CR26 doi: 10.1016/j.ccell.2018.08.008 – volume: 23 start-page: 481 issue: 4 year: 2018 ident: 1353_CR53 publication-title: Oncologist doi: 10.1634/theoncologist.2017-0398 – volume: 82 start-page: 1082 issue: 6 year: 1998 ident: 1353_CR6 publication-title: Cancer doi: 10.1002/(SICI)1097-0142(19980315)82:6<1082::AID-CNCR11>3.0.CO;2-2 – volume: 38 start-page: 1073 issue: 15_suppl year: 2020 ident: 1353_CR59 publication-title: J Clin Oncol doi: 10.1200/JCO.2020.38.15_suppl.1073 – volume: 14 start-page: 4038 issue: 13 year: 2008 ident: 1353_CR31 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-07-4379 – volume: 22 start-page: 24 issue: 1 year: 2015 ident: 1353_CR4 publication-title: Ann Surg Oncol doi: 10.1245/s10434-014-3890-4 – volume: 119 start-page: 1420 issue: 6 year: 2009 ident: 1353_CR38 publication-title: J Clin Invest doi: 10.1172/JCI39104 – volume: 7 start-page: R1028 issue: 6 year: 2005 ident: 1353_CR23 publication-title: Breast Cancer Res doi: 10.1186/bcr1341 – ident: 1353_CR1 – volume: 11 start-page: 129 year: 2013 ident: 1353_CR12 publication-title: World J Surg Oncol doi: 10.1186/1477-7819-11-129 – volume: 73 start-page: 1078 issue: 9 year: 1973 ident: 1353_CR5 publication-title: N Y State J Med – volume: 28 start-page: 1506 issue: 11 year: 2004 ident: 1353_CR14 publication-title: Am J Surg Pathol doi: 10.1097/01.pas.0000138183.97366.fd – volume: 109 start-page: 1 issue: 6 year: 2017 ident: 1353_CR30 publication-title: J Natl Cancer Inst. doi: 10.1093/jnci/djw292 – volume: 126 start-page: 471 issue: 2 year: 2011 ident: 1353_CR45 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-011-1359-8 – volume: 118 start-page: 1333 issue: 9 year: 2019 ident: 1353_CR58 publication-title: J Formos Med Assoc doi: 10.1016/j.jfma.2018.12.004 – volume: 121 start-page: 2750 issue: 7 year: 2011 ident: 1353_CR42 publication-title: J Clin Invest doi: 10.1172/JCI45014 – volume: 17 start-page: 615 year: 2001 ident: 1353_CR43 publication-title: Annu Rev Cell Dev Biol doi: 10.1146/annurev.cellbio.17.1.615 – volume: 247 start-page: 214 issue: 2 year: 2019 ident: 1353_CR7 publication-title: J Pathol doi: 10.1002/path.5184 – volume: 36 start-page: 2275 issue: 16 year: 2017 ident: 1353_CR33 publication-title: Oncogene doi: 10.1038/onc.2016.381 – volume: 18 start-page: 116 issue: 2 year: 2014 ident: 1353_CR55 publication-title: Contemp Oncol (Pozn) – volume: 19 start-page: 881 issue: 1 year: 2019 ident: 1353_CR16 publication-title: BMC Cancer doi: 10.1186/s12885-019-6052-z – volume: 18 start-page: 94 issue: 1 year: 2011 ident: 1353_CR54 publication-title: Ann Surg Oncol doi: 10.1245/s10434-010-1198-6 – volume: 3 start-page: 8 year: 2017 ident: 1353_CR35 publication-title: NPJ Breast Cancer doi: 10.1038/s41523-017-0011-0 – volume: 2 start-page: 31 issue: 1 year: 2013 ident: 1353_CR9 publication-title: Exp Hematol Oncol doi: 10.1186/2162-3619-2-31 – volume: 31 start-page: 1661 issue: 11 year: 2018 ident: 1353_CR36 publication-title: Mod Pathol doi: 10.1038/s41379-018-0081-z – volume: 21 start-page: 333 issue: 5–6 year: 2016 ident: 1353_CR48 publication-title: Crit Rev Oncog doi: 10.1615/CritRevOncog.2017021307 – volume: 23 start-page: 3859 issue: 14 year: 2017 ident: 1353_CR27 publication-title: Clin Cancer Res doi: 10.1158/1078-0432.CCR-16-2857 – volume: 94 issue: 52 year: 2015 ident: 1353_CR46 publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000002341 – volume: 29 start-page: 347 issue: 3 year: 2005 ident: 1353_CR19 publication-title: Am J Surg Pathol doi: 10.1097/01.pas.0000152133.60278.d2 – volume: 22 start-page: 188 issue: 2 year: 1998 ident: 1353_CR18 publication-title: Am J Surg Pathol doi: 10.1097/00000478-199802000-00006 – volume: 73 start-page: 273 issue: 2 year: 2018 ident: 1353_CR15 publication-title: Histopathology doi: 10.1111/his.13514 – volume: 14 start-page: 147 issue: 3 year: 2014 ident: 1353_CR3 publication-title: Nat Rev Cancer doi: 10.1038/nrc3637 – volume: 143 start-page: 1492 issue: 12 year: 2019 ident: 1353_CR8 publication-title: Arch Pathol Lab Med doi: 10.5858/arpa.2019-0396-RA – volume: 120 start-page: 627 issue: 3 year: 2010 ident: 1353_CR52 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-010-0780-8 – ident: 1353_CR51 – volume: 3 start-page: 509 issue: 4 year: 2017 ident: 1353_CR57 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2016.5281 – volume: 209 start-page: 445 issue: 4 year: 2006 ident: 1353_CR24 publication-title: J Pathol doi: 10.1002/path.2004 – volume: 7 start-page: 944 issue: 4 year: 2008 ident: 1353_CR25 publication-title: Mol Cancer Ther doi: 10.1158/1535-7163.MCT-07-0570 – volume: 69 start-page: 4116 issue: 10 year: 2009 ident: 1353_CR21 publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-08-3441 – volume: 130 start-page: 345 issue: 1 year: 2011 ident: 1353_CR50 publication-title: Breast Cancer Res Treat doi: 10.1007/s10549-011-1686-9 – volume: 23 start-page: 1438 issue: 11 year: 2010 ident: 1353_CR32 publication-title: Mod Pathol. doi: 10.1038/modpathol.2010.141 – volume: 11 start-page: 918 issue: 12 year: 1987 ident: 1353_CR11 publication-title: Am J Surg Pathol doi: 10.1097/00000478-198712000-00002 – volume: 106 start-page: 13820 issue: 33 year: 2009 ident: 1353_CR22 publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0905718106 – volume: 15 start-page: 273 issue: 5 year: 2018 ident: 1353_CR44 publication-title: Nat Rev Clin Oncol doi: 10.1038/nrclinonc.2018.28 – volume: 59 start-page: 1079 issue: 10 year: 2006 ident: 1353_CR10 publication-title: J Clin Pathol doi: 10.1136/jcp.2005.030536 – volume: 14 issue: 11 year: 2019 ident: 1353_CR28 publication-title: PLoS One doi: 10.1371/journal.pone.0224726 – volume: 70 start-page: 255 issue: 3 year: 2017 ident: 1353_CR34 publication-title: J Clin Pathol doi: 10.1136/jclinpath-2016-203874 |
| SSID | ssj0017858 |
| Score | 2.6049092 |
| SecondaryResourceType | review_article |
| Snippet | Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is therapeutically challenging and aggressive. MpBC is defined by the... Abstract Metaplastic breast cancer (MpBC) is an exceedingly rare breast cancer variant that is therapeutically challenging and aggressive. MpBC is defined by... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 121 |
| SubjectTerms | 1-Phosphatidylinositol 3-kinase AKT protein Biomedical and Life Sciences Biomedicine Breast cancer Breast Neoplasms - genetics Breast Neoplasms - metabolism Breast Neoplasms - pathology Breast Neoplasms - therapy Cancer Research Cancer therapies Care and treatment Cell adhesion & migration Cell cycle Cell Line, Tumor Chemotherapy Clinical trials Comparative analysis Epidermal growth factor Epidermal growth factors Epithelial-Mesenchymal Transition Epithelial-to-mesenchymal transition Female Gene expression Genes, Neoplasm - genetics Genomics Humans Immune response Kinases Medical prognosis Mesenchyme Metaplasia - genetics Metaplasia - metabolism Metaplasia - pathology Metaplasia - therapy Metaplastic breast cancer Molecular Targeted Therapy - methods Morphology Mutation Nitric oxide Nitric Oxide Synthase - metabolism NOS signaling Oncology Phenotypes Phosphatidylinositol 3-Kinases - metabolism PI3K signaling Prognosis Proteomics Radiation therapy Radiotherapy Review Smooth muscle Stem cells Surgical Oncology Triple Negative Breast Neoplasms - genetics Triple Negative Breast Neoplasms - metabolism Triple Negative Breast Neoplasms - pathology Triple Negative Breast Neoplasms - therapy Tumors Wnt protein Wnt Signaling Pathway β-Catenin |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwEB6hHhAXBC2PQEFGQnCAqE7i13JbEFWFBCcq9WbZzlhFYrPVbnqgvx6PkyxNEXDhGo8j2_OwxzP-BuClQC7RS1lijclBaYQsnQix5CLqRlXBa8xZvl_Uyan4dCbPrpX6opywAR54WLijGBT3LXJ0NYrIo6GAvcBKpS8iOCTryxd8cqbG-IE20kxPZIw62iZLLU1JrhKnQg_l1Wwbymj9v9vka5vSzYTJG1HTvBkd34O74ymSLYfR34db2O3DwbJLHvTqB3vFcl5nvjDfh9ufx_D5AfgloxTyDZ4PaeuM8jcpNsDWka2wdxfpLJ1-yTylqvcskEhs3rHp-SSLmHFAt8x1LVtNlXWZ87gZJGn7AE6PP379cFKORRbKoHTTlzpZ3oVPdLpqG0waKbHVi9ob2bqm8rWLJmCoI8bgTXBKEDvaQEhzJtYcm4ew1607fAzMSB44JgfQEOiNk65VOv3XR-Mk1Z8ooJrW3IYRgZwKYXy32RMxyg58solPNvPJXhXwZtfnYsDf-Cv1e2LljpKws_OHJFF2lCj7L4kq4DUJgiUNT8MLbnyokCZJWFl2mVy2epG8eF3A4YwyaWaYN0-iZEfLsLW1UDVd9KiqgBe7ZupJ2W4dri-Jhl4IJxpVwKNB8nZTahpCbjWmAD2Tydmc5y3dt_OMG66VoANmAW8n6f01rD-v6ZP_saZP4U5N2kf38eIQ9vrNJT5Lp7neP8-K-xMMW0i_ priority: 102 providerName: Directory of Open Access Journals – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1LbxQxDI6gSIgLgpbHQEFBQnCAEfPIa7ktK6oKCU5U6i1KMo6KxM5Wu9MD_fXYmQed8pC4Js5oEttJHNufGXspoJDgpcyhAjRQaiFzJ0LMCxF1rcrgNaQo3y_q-ER8OpWnA0wO5cJc9d-XRr3b4R4rTU5GTkElGvLLm-yWxEaS5pVaTR4DbaQZk2L-OG528CR8_t934SvH0PUQyWt-0nT8HN1jd4d7I1_2jL7PbkC7zw6WLdrM6x_8FU-RnOmJfJ_d_jw4zA-YX3IKGt_CWR-ozilik7wBfBP5Gjp3jrdn_CT3FJze8UBCsH3Px4RJHiEhf-64axu-Hmvpcudh28vO7gE7Ofr4dXWcD2UV8qB03eUa99qFRzpdNjWgDkpo9KLyRjauLn3logkQqggxeBOcEqrwTRMIW87EqoD6IdtrNy08ZtzIIhSAJp8hmBsnXaM0ftdH4yRVnMhYOa65DQPmOJW--G6T7WGU7flkkU828cleZuzNNOa8R9z4J_UHYuVESWjZqQGFyA7KZ2OgKUABrgIRi2go6ENAqbBFBAcZe02CYEmn8feCG1ITcJKEjmWXaKRVC7TbdcYOZ5Soi2HePYqSHfaCna2EquhpR5UZezF100iKb2thc0E0lBOMNCpjj3rJm6ZU14TVakzG9EwmZ3Oe97TfzhJSuFaCrpQZeztK76_f-vuaPvk_8qfsTkV6Rm_t4pDtddsLeIY3tc4_Tyr6E6fyOCI priority: 102 providerName: Springer Nature |
| Title | A comprehensive overview of metaplastic breast cancer: clinical features and molecular aberrations |
| URI | https://link.springer.com/article/10.1186/s13058-020-01353-z https://www.ncbi.nlm.nih.gov/pubmed/33148288 https://www.proquest.com/docview/2462198761 https://www.proquest.com/docview/2457968766 https://pubmed.ncbi.nlm.nih.gov/PMC7640663 https://doaj.org/article/fc60bde0ea2e4f0f820084e160ea4cae |
| Volume | 22 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfR1db9Mw0IJNQrwg2PgIjMpICB4gWj5sx-UFtdOmCYkJTVSqeLFs58yQaFra7oH9eu6cpKND7CVS4kuUs-_Od-f7YOy1gEyCkzKFAtBAKYVMrfAhzUSoSpV7V0GM8j1TpxPxaSqnncNt1YVV9jIxCup67slHflgIVZCBrPKPi18pdY2i09WuhcZdtpujJkKtG6rpxuCixvO6zS6SqRR53ifNaHW4QtktdUrGU0atH9KrrY0p1u__V0r_tU3dDKG8cY4at6eTh-xBp1fyUUsIj9gdaPbY_qhBm3r2m7_hMdIzutD32L3P3YH6PnMjTkHlS7hoA9k5RXTSTPB54DNY2wVq1_hJ7ih4fc09EcnyA-8TKnmAWBl0xW1T81nfa5dbB8uWtlaP2eTk-OvRadq1XUi9qsp1WqEsHjqEq_K6BORRCXU1LJyWtS1zV9igPfgiQPBOe6uEylxde6o9p0ORQfmE7TTzBp4xrmXmM0CTUFMZHCttrSr8rgvaSupIkbC8n3Pju5rk1Brjp4m2iVamXSeD62TiOpmrhL3bvLNoK3LcCj2mpdxAUjXt-GC-_G465jTBEwqQgS1AhCxoCgoRkCt8IryFhL0lQjDE8_h73napC4gkVc8yIzTiiiHa9VXCDrYgkVf99nBPSqaTFStzTdkJe7UZpjcp_q2B-SXBUM4wwqiEPW0pb4NSWVItV60TVm3R5BbO2yPNj4tYSbxSglTOhL3vqff6t_4_p89vx-IFu18QX5HvXRywnfXyEl6i5rZ2g8ieA7Y7Pj77co53R-poEL0geD0ff8PrpBj9AeRyRhA |
| linkProvider | ProQuest |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR1dTxQxcIJHor4YBT9WUWvix4Ns2O223Z4JMYdCQD5iDCS81W53VkxkD--OGPhx_jY73d3Dw8gbr9tps9OZznQ6XwAvBSYSCylj5OgNlEzI2ApXxYmo8kylrsgxRPnuqc0D8elQHs7B7y4XhsIqO5kYBHU5dPRGvsKF4mQgq_T9yc-YukaRd7VroWHb1grlaigx1iZ2bOPZL2_CjVe3Pnp6v-J8Y33_w2bcdhmIncqzSZx70dMvbIF5WmboWVJimfd5oWVps7TgttIOHa-wcoV2VgmVFGXpqNSarniCmV_3BswLekDpwfza-t7nL1M_Rq5Dh1AvjmQsRZp2aTtarYy99pA6JvMtoeYT8fmMagwdBP7VE38pystBnJc8uUFBbtyFO-3Nlg0aVrwHc1gvwOKg9lb98Rl7zUKsaXjEX4Cbu61LfxGKAaOw9hEeNaH0jGJKiRZsWLFjnNgTf7_3S7KCwucnzBGbjt6xLqWTVRhqk46ZrUt23HX7ZX6rRw13j-_DwbWQ5AH06mGNj4BpmbgEvVGqqRCPlbZUuV-3qLSV1BMjgrTbc-PaqujUnOOHCdaRVqahk_F0MoFO5jyCt9M5J01NkCuh14iUU0iq5x0-DEffTCseTOUIBUzQchRVUmkKSxGYKv9FOIsRvCFGMCR1_O852yZPeCSpfpcZeDOS99OM5xEszUB6aeFmhztWMq20GpuLsxXBi-kwzaQIvBqHpwRDWcseRkXwsOG8KUpZRtVktY4gn-HJGZxnR-rvR6GWea4EXXojWO649-K3_r-nj6_G4jnc2tzf3TE7W3vbT-A2pzNGngCxBL3J6BSf-nvkpHjWHlYGX69bPvwBovWHKA |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV1Lb9QwELagSBUXBC3QQAEjIThA1MTxa7ktj1V5VRyo1JtlO2OKxGZXu-mB_no8TrI05SFxjcdRnJmxPZ5vPhPyhEMhwAmRA4MYoFRc5Jb7kBc8qEqW3ilIKN8jeXjM35-IkwtV_AntPqQku5oGZGlq2oNlHToX1_JgHWdeoXMMfQq8uCE_v0qu8bhWI6jrmE03eQSlhR5KZf7Yb7QcJdb-3-fmC4vTZeDkpexpWpRmN8mNfjdJp536b5Er0OyQ3WkTI-n5D_qUJnxnOjjfIduf-jT6LnFTilDyFZx28HWKOE7MEdBFoHNo7TLuqeMrqUPIeks9msbqJR3KKGmAxAe6prap6Xy4YZdaB6vOota3yfHs7ZfXh3l_2ULuparaXMUZeOKinCrrCqJnCqjVhDktaluVjtmgPXgWIHinvZVcFq6uPTLO6cAKqO6QrWbRwB6hWhS-gBgIaiS_scLWUsX3uqCtwHsoMlIO_9z4nokcL8T4blJEoqXp9GSinkzSkznPyPNNn2XHw_FP6Veoyo0kcminB4vVV9O7pAkehwAFWAY8FEEjFIRDKeMT7i1k5BkagkFPj5_nbV-wEAeJnFlmGkM3NonRvMrI_kgyeqgfNw-mZPoZYm0YlwwPfGSZkcebZuyJqLcGFmcog5XCUUZm5G5neZshVRUyuGqdETWyydGYxy3Nt9PEH64kx41mRl4M1vvrs_7-T-_9n_gjsv35zcx8fHf04T65ztDl8DCe75OtdnUGD-JWrnUPk7f-BKcoQ3c |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+comprehensive+overview+of+metaplastic+breast+cancer%3A+clinical+features+and+molecular+aberrations&rft.jtitle=Breast+cancer+research+%3A+BCR&rft.au=Reddy%2C+Tejaswini+P&rft.au=Rosato%2C+Roberto+R&rft.au=Li%2C+Xiaoxian&rft.au=Moulder%2C+Stacy&rft.date=2020-11-04&rft.pub=BioMed+Central&rft.issn=1465-5411&rft.eissn=1465-542X&rft.volume=22&rft.spage=1&rft_id=info:doi/10.1186%2Fs13058-020-01353-z |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1465-542X&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1465-542X&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1465-542X&client=summon |